0001209191-21-039081.txt : 20210609
0001209191-21-039081.hdr.sgml : 20210609
20210609060333
ACCESSION NUMBER: 0001209191-21-039081
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210604
FILED AS OF DATE: 20210609
DATE AS OF CHANGE: 20210609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Connelly Stephen
CENTRAL INDEX KEY: 0001746808
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38692
FILM NUMBER: 211003900
MAIL ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 108
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Equillium, Inc.
CENTRAL INDEX KEY: 0001746466
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821554746
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 105
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 412-5302
MAIL ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 105
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-04
0
0001746466
Equillium, Inc.
EQ
0001746808
Connelly Stephen
2223 AVENIDA DE LA PLAYA
SUITE 105
LA JOLLA
CA
92037
1
1
0
0
Chief Scientific Officer
Common Stock
2021-06-04
4
M
0
6509
2.80
A
999509
D
Common Stock
2021-06-04
4
S
0
6509
7.0058
D
993000
D
Common Stock
2021-06-04
4
M
0
7030
4.75
A
1000030
D
Common Stock
2021-06-04
4
S
0
7030
7.005
D
993000
D
Common Stock
2021-06-07
4
M
0
8490
2.80
A
1001490
D
Common Stock
2021-06-07
4
S
0
8490
7.0842
D
993000
D
Common Stock
2021-06-07
4
M
0
13900
4.75
A
1006900
D
Common Stock
2021-06-07
4
S
0
13900
7.1413
D
993000
D
Common Stock
2021-06-08
4
M
0
10495
4.75
A
1003495
D
Common Stock
2021-06-08
4
S
0
10495
7.1763
D
993000
D
Employee Stock Option (right to buy)
2.80
2021-06-04
4
M
0
6509
0.00
D
2021-05-19
2030-05-18
Common Stock
6509
8490
D
Employee Stock Option (right to buy)
4.75
2021-06-04
4
M
0
7030
0.00
D
2019-12-10
2029-12-09
Common Stock
7030
24845
D
Employee Stock Option (right to buy)
2.80
2021-06-07
4
M
0
8490
0.00
D
2021-05-19
2030-05-18
Common Stock
8490
0
D
Employee Stock Option (right to buy)
4.75
2021-06-07
4
M
0
13900
0.00
D
2019-12-10
2029-12-09
Common Stock
13900
10945
D
Employee Stock Option (right to buy)
4.75
2021-06-08
4
M
0
10945
0.00
D
2019-12-10
2029-12-09
Common Stock
10945
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.04, inclusive. The reporting
person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full
information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 to $7.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4.
The option, representing a right to purchase a total of 14,999 shares, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, and in 36 equal monthly installments thereafter.
The option, representing a right to purchase a total of 31,875 shares, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, and in 36 equal monthly installments thereafter.
/s/ Jason A. Keyes, Attorney -in-Fact for Stephen Connelly
2021-06-08